EPAM three-lens brief
Evidence-based stock research on EPAM. Three independent lenses — Quality, Momentum, Context — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Moved -4.66% yesterday. · Trading at 0% of its 52-week range — deep in the lower band.
- Moved -4.66% yesterday.
- Trading at 0% of its 52-week range — deep in the lower band.
- RSI at 14 — technically oversold.
- Underperforming SPY by 46.3pp over 30 days.
- Analyst mean target $147.88 — 63% above current (17 analysts).
EPAM closed at $90.71 (-4.66%) as of 2026-05-13. Market cap: $4.74B. P/E (trailing) 13.0. Positives: analyst mean target $147.88 — 63% above current (17 analysts).. Concerns: moved -4.66% yesterday.; trading at 0% of its 52-week range — deep in the lower band.. Last quarter: Revenue $1.40B, net income $82.52M, free cash flow $692.90M.
Why three lenses on EPAM, not one.
A single reasoning model has blind spots it doesn’t know about. We examine EPAMacross Quality (fundamentals), Momentum (price action and sentiment), and Context (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/EPAM" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath EPAM brief"></iframe>